North America
African, Asian Ancestry Patients Less Likely to Be Eligible for New Precision Oncology Drugs
Premium
A new study found that fewer African and Asian patients had clinically actionable alterations for lung, breast, and colorectal cancer.
Immunocore Outlines Strategic Priorities on Kimmtrak and TCR Therapy Pipeline
The firm is expanding its melanoma portfolio while launching new trials of T-cell receptor therapies in oncology, infectious disease, and autoimmune disease.
Biocytogen Partners With Acepodia to Develop Dual-Payload Bispecific Antibody
The firms will work together to create a bispecific antibody with two anti-cancer payloads and evaluate its therapeutic potential.
Platforms using natural language processing are showing promise in scanning patients' records for biomarkers and other enrollment criteria for clinical trials.
Repare Therapeutics Shuffles Pipeline, Pauses Some Programs Pending Partnership
The firm will pause development of lunresertib and camonsertib while focusing on development of two newer programs.
Jan 10, 2025
A2 Biotherapeutics Raises $80M in Series C Funding
Jan 8, 2025
Maze Therapeutics Files Plans for Proposed IPO
Jan 8, 2025